NCT03776149

Brief Summary

The aim of the current project is to understand the effect of dietary nitrates (via beet-root juice), on its ability to improve parameters of cardiovascular health in cancer survivors with a history of anthracycline chemotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2018

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 14, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

2.1 years

First QC Date

May 14, 2018

Last Update Submit

March 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Left ventricular function

    Left ventricular function as measured by transthoracic echocardiography

    The change between day 1 and day 21

Secondary Outcomes (2)

  • Change in Vascular function

    The change between day 1 and day 21

  • Change in Blood pressure

    The change between day 1 and day 21

Study Arms (2)

Beetroot juice (dietary nitrate)

EXPERIMENTAL

Over the 7 days preceding each testing session, participants will consume 140 ml per day of beetroot juice (Beet It (HeartBeet Ltd.), Ipswich, UK). During this time participants will be asked to abstain from use of antiseptic mouthwash as this has been shown to temporarily kill the bacteria that facilitate the reduction of nitrate to nitrite. All participants will be asked to refrain from consuming any antioxidant (e.g., Vit E or Fish Oil) supplements during the course of the study as these may impact the study findings.

Dietary Supplement: Beetroot juice

Black currant juice (placebo control)

PLACEBO COMPARATOR

Over the 7 days preceding each testing session, participants will consume 140 ml per day of a nitrate-depleted placebo. During this time participants will be asked to abstain from use of antiseptic mouthwash as this has been shown to temporarily kill the bacteria that facilitate the reduction of nitrate to nitrite. All participants will be asked to refrain from consuming any antioxidant (e.g., Vit E or Fish Oil) supplements during the course of the study as these may impact the study findings.

Dietary Supplement: Black currant juice

Interventions

Beetroot juiceDIETARY_SUPPLEMENT

Following randomization on day 1, subjects will consume either the nitrate or nitrate-free beverage for 7 days with outcome measurements performed on day 7. Following a 7 day washout, subjects will then consume the crossover beverage for 7 days with outcome measures performed on day 21.

Beetroot juice (dietary nitrate)
Black currant juiceDIETARY_SUPPLEMENT

Following randomization on day 1, subjects will consume either the nitrate or nitrate-free beverage for 7 days with outcome measurements performed on day 7. Following a 7 day washout, subjects will then consume the crossover beverage for 7 days with outcome measures performed on day 21.

Black currant juice (placebo control)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • cancer survivors (at least 1 year post treatment)
  • Prior administration of anthracycline chemotherapy
  • partial/complete remission

You may not qualify if:

  • Unable to provide informed consent
  • Kidney disease
  • High risk of kidney stones
  • Diagnosed hemochromatosis
  • Pregnant, breast feeding, or planning to become pregnant
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kansas State University - Clinical Integrative Physiology Laboratory

Manhattan, Kansas, 66506, United States

Location

Related Publications (4)

  • Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011 Jun 20;13(3):R64. doi: 10.1186/bcr2901.

    PMID: 21689398BACKGROUND
  • Mulrooney DA, Blaes AH, Duprez D. Vascular injury in cancer survivors. J Cardiovasc Transl Res. 2012 Jun;5(3):287-95. doi: 10.1007/s12265-012-9358-7. Epub 2012 Mar 29.

    PMID: 22456863BACKGROUND
  • Chaosuwannakit N, D'Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, Melin SA, Ellis LR, Torti FM, Little WC, Hundley WG. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol. 2010 Jan 1;28(1):166-72. doi: 10.1200/JCO.2009.23.8527. Epub 2009 Nov 9.

    PMID: 19901105BACKGROUND
  • Duquaine D, Hirsch GA, Chakrabarti A, Han Z, Kehrer C, Brook R, Joseph J, Schott A, Kalyanaraman B, Vasquez-Vivar J, Rajagopalan S. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med. 2003 May;8(2):101-7. doi: 10.1191/1358863x03vm476oa.

    PMID: 14518612BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The supplement and placebo will be distributed to the individual by a member of the research team who is not involved with data collection or analysis.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: This study utilizes a 7-day randomized, double-blind, placebo-controlled crossover study design, in which individuals are initially supplemented with a nitrate-rich supplement in the form of a specifically formulated beetroot juice, or nitrate-poor placebo. Individuals will then entered a 7-day washout period before entering the opposing arm of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 14, 2018

First Posted

December 14, 2018

Study Start

May 10, 2018

Primary Completion

May 31, 2020

Study Completion

May 31, 2020

Last Updated

March 31, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations